Steris (STE) Cash from Investing Activities (2018 - 2026)
Steris (STE) posted quarterly Cash from Investing Activities of -$217.2 million for Q1 2026, down 211.17% year-over-year from $195.4 million in Q1 2025, and down 120.51% quarter-over-quarter from -$98.5 million in Q4 2025.
Steris (STE) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Steris' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$217.2 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 211.17% year-over-year to -$217.2 million; the TTM figure through Mar 2026 stood at -$512.5 million (down 231.82% YoY), while the FY2026 annual figure was -$512.5 million, down 231.82% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$217.2 million, down from -$98.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $687.8 million in Q2 2024, with the low at -$606.2 million in Q3 2023.
- The 5-year median for Cash from Investing Activities is -$98.4 million (2022), against an average of -$76.5 million.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities slumped 519.08% in 2023, then soared 1132.79% in 2024.
- Steris' Cash from Investing Activities stood at -$98.4 million in 2022, then fell by 20.84% to -$118.9 million in 2023, then slipped by 4.19% to -$123.9 million in 2024, then gained by 20.5% to -$98.5 million in 2025, then slumped by 120.51% to -$217.2 million in 2026.
- Business Quant data shows STE's Cash from Investing Activities at -$217.2 million in Q1 2026, -$98.5 million in Q4 2025, and -$88.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.29 Bn | 18.88 Bn | 1.54 Bn | -190.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -108.50 Mn |
| Jun 30, 2026 | -108.50 Mn |
| Mar 31, 2026 | -217.20 Mn |
| Mar 31, 2026 | -217.20 Mn |
| Dec 31, 2025 | -98.50 Mn |
| Dec 31, 2025 | -98.50 Mn |
| Sep 30, 2025 | -88.30 Mn |
| Sep 30, 2025 | -88.30 Mn |
| Jun 30, 2025 | -108.50 Mn |
| Jun 30, 2025 | -108.50 Mn |
| Mar 31, 2025 | -69.80 Mn |
| Mar 31, 2025 | -69.80 Mn |
| Dec 31, 2024 | -123.90 Mn |
| Dec 31, 2024 | -123.90 Mn |
| Sep 30, 2024 | -105.30 Mn |
| Sep 30, 2024 | -105.30 Mn |
| Jun 30, 2024 | 687.80 Mn |
| Jun 30, 2024 | 687.80 Mn |
| Mar 31, 2024 | -95.65 Mn |
| Mar 31, 2024 | -95.65 Mn |